Treatment of candidal urinary tract infection with nifuratel.
- 16 October 1976
- Vol. 2 (6041) , 908-910
- https://doi.org/10.1136/bmj.2.6041.908
Abstract
Three patients with candidal urinary tract infections were successfully treated with oral nifuratel, a nitrofuran antimicrobial agent active against yeast and Trichomonas as well as urinary bacterial pathogens. The recommended dose is 400 mg thrice daily for a week. No side effects that could be attributed to the treatment were noted. Minimum ibhibitory concentration determinations for nifuratel against Candida strains of five species showed that 48 out of 59 organisms were inhibited by 50 mg/1 or less, the three strains of Candida species eliminated from our treated patients having MICs of nifuratel in the range of 10-50 mg/1.Keywords
This publication has 5 references indexed in Scilit:
- Yeasts in the urineJournal of Antimicrobial Chemotherapy, 1975
- Sensitivity of Yeasts to 5-FluorocytosineJournal of Medical Microbiology, 1973
- Pharmacokinetic Studies on the Oral Antimycotic Agent 5-Fluorocytosine in Individuals with Normal and Impaired Kidney FunctionChemotherapy, 1973
- Antibacterial activity of nifuratel in urine and serumJournal of Clinical Pathology, 1972
- NIFURATEL IN URINARY INFECTIONSBritish Journal of Urology, 1969